Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chubb
Dow
Accenture
Colorcon
US Department of Justice
Baxter
US Army
Fish and Richardson
Medtronic

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020578

« Back to Dashboard

NDA 020578 describes ZOLADEX, which is a drug marketed by Tersera Theraps Llc and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ZOLADEX profile page.

The generic ingredient in ZOLADEX is goserelin acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the goserelin acetate profile page.
Summary for 020578
Tradename:ZOLADEX
Applicant:Tersera Theraps Llc
Ingredient:goserelin acetate
Patents:3
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020578
Medical Subject Heading (MeSH) Categories for 020578
Suppliers and Packaging for NDA: 020578
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578 NDA AstraZeneca Pharmaceuticals LP 0310-0951 0310-0951-30 1 POUCH in 1 CARTON (0310-0951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;IMPLANTATIONStrengthEQ 10.8MG BASE
Approval Date:Jan 11, 1996TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Apr 13, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Apr 9, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Feb 26, 2021Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020578

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Subscribe ➤ Subscribe
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Subscribe ➤ Subscribe
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
AstraZeneca
Queensland Health
Federal Trade Commission
McKesson
Merck
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot